BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 16530733)

  • 1. Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro.
    Maher S; McClean S
    Biochem Pharmacol; 2006 Apr; 71(9):1289-98. PubMed ID: 16530733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vitro cytotoxicity of the antimicrobial peptide P34.
    Vaucher RA; da Motta Ade S; Brandelli A
    Cell Biol Int; 2010 Feb; 34(3):317-23. PubMed ID: 19947909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cyclization of magainin 2 and melittin analogues on structure, function, and model membrane interactions: implication to their mode of action.
    Unger T; Oren Z; Shai Y
    Biochemistry; 2001 May; 40(21):6388-97. PubMed ID: 11371201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of antimicrobial activity against Listeria and cytotoxicity of native melittin and its mutant variants.
    Wu X; Singh AK; Wu X; Lyu Y; Bhunia AK; Narsimhan G
    Colloids Surf B Biointerfaces; 2016 Jul; 143():194-205. PubMed ID: 27011349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the cytotoxicity of antimicrobial peptide P40 on eukaryotic cells.
    Vaucher RA; Teixeira ML; Brandelli A
    Curr Microbiol; 2010 Jan; 60(1):1-5. PubMed ID: 19727943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
    Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
    Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
    Shin SY; Kang JH; Hahm KS
    J Pept Res; 1999 Jan; 53(1):82-90. PubMed ID: 10195445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, characterization and expression of a novel hybrid peptides melittin (1-13)-LL37 (17-30).
    Wu R; Wang Q; Zheng Z; Zhao L; Shang Y; Wei X; Liao X; Zhang R
    Mol Biol Rep; 2014 Jul; 41(7):4163-9. PubMed ID: 24871991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity.
    Tachi T; Epand RF; Epand RM; Matsuzaki K
    Biochemistry; 2002 Aug; 41(34):10723-31. PubMed ID: 12186559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melittin as a permeability enhancer II: in vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae.
    Maher S; Feighery L; Brayden DJ; McClean S
    Pharm Res; 2007 Jul; 24(7):1346-56. PubMed ID: 17380268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Magainins: sequence factors relevant to increased antimicrobial activity and decreased hemolytic activity.
    Cuervo JH; Rodriguez B; Houghten RA
    Pept Res; 1988; 1(2):81-6. PubMed ID: 2980783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli.
    Lee JK; Seo CH; Luchian T; Park Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):495-506. PubMed ID: 26552969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melittin exhibits necrotic cytotoxicity in gastrointestinal cells which is attenuated by cholesterol.
    Maher S; McClean S
    Biochem Pharmacol; 2008 Mar; 75(5):1104-14. PubMed ID: 18068148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2.
    Matsuzaki K; Sugishita K; Fujii N; Miyajima K
    Biochemistry; 1995 Mar; 34(10):3423-9. PubMed ID: 7533538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial efficacy of Cecropin A (1-7)- Melittin and Lactoferricin (17-30) against multi-drug resistant Salmonella Enteritidis.
    Gourkhede DP; Bhoomika S; Pathak R; Yadav JP; Nishanth D; Vergis J; Malik SVS; Barbuddhe SB; Rawool DB
    Microb Pathog; 2020 Oct; 147():104405. PubMed ID: 32707313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced membrane pore formation through high-affinity targeted antimicrobial peptides.
    Arnusch CJ; Pieters RJ; Breukink E
    PLoS One; 2012; 7(6):e39768. PubMed ID: 22768121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro biological activities of magainin alone or in combination with nisin.
    Cruz-Chamorro L; Puertollano MA; Puertollano E; de Cienfuegos GA; de Pablo MA
    Peptides; 2006 Jun; 27(6):1201-9. PubMed ID: 16356589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
    Shin SY; Lee MK; Kim KL; Hahm KS
    J Pept Res; 1997 Oct; 50(4):279-85. PubMed ID: 9352466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antibacterial action of heat in combination with nisin and magainin II amide.
    Ueckert JE; ter Steeg PF; Coote PJ
    J Appl Microbiol; 1998 Sep; 85(3):487-94. PubMed ID: 9750279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cecropin A - magainin 2 hybrid peptides having potent antimicrobial activity with low hemolytic effect.
    Shin SY; Kang JH; Lee MK; Kim SY; Kim Y; Hahm KS
    Biochem Mol Biol Int; 1998 May; 44(6):1119-26. PubMed ID: 9623765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.